| Zenotech Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532039 |
NSE Symbol : - |
P/E(TTM) : 100.81 |
|
ISIN Demat : INE486F01012 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.47 |
|
Book Value(₹) : 15.77 |
Market Cap(₹Cr) : 289.16 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 10.23 | 8.64 | 11.11 | 10.22 | 8.75 | 8.89 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10.23 | 8.64 | 11.11 | 10.22 | 8.75 | 8.89 |
| Other Operating Income | 1.00 | 1.00 | 1.02 | 1.02 | 1.02 | 1.02 |
| Other Income | 0.75 | 0.59 | 0.49 | 1.00 | 1.69 | 0.34 |
| Total Income | 11.99 | 10.23 | 12.62 | 12.24 | 11.46 | 10.25 |
| Total Expenditure | 8.95 | 7.18 | 7.71 | 7.37 | 7.36 | 6.48 |
| PBIDT | 3.04 | 3.05 | 4.91 | 4.87 | 4.10 | 3.77 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 3.04 | 3.05 | 4.91 | 4.87 | 4.10 | 3.77 |
| Depreciation | 1.78 | 1.77 | 1.73 | 1.76 | 1.75 | 1.73 |
| Tax | -2.13 | 0.22 | 2.49 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.22 | 0.07 | -0.54 | 1.42 | 1.00 | 0.76 |
| Reported Profit After Tax | -0.84 | 0.99 | 1.23 | 1.69 | 1.35 | 1.29 |
| Extra-ordinary Items | -0.12 | 0.00 | -0.01 | 0.34 | 0.77 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.72 | 0.99 | 1.24 | 1.35 | 0.58 | 1.29 |
| EPS (Unit Curr.) | -0.14 | 0.16 | 0.20 | 0.28 | 0.22 | 0.21 |
| EPS (Adj) (Unit Curr.) | -0.14 | 0.16 | 0.20 | 0.28 | 0.22 | 0.21 |
| Calculated EPS (Unit Curr.) | -0.14 | 0.16 | 0.20 | 0.28 | 0.22 | 0.21 |
| Calculated EPS (Adj) (Unit Curr.) | -0.14 | 0.16 | 0.20 | 0.28 | 0.22 | 0.21 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.55 | 0.65 | 0.81 | 1.11 | 0.88 | 0.85 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.55 | 0.65 | 0.81 | 1.11 | 0.88 | 0.85 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 29.72 | 35.30 | 44.19 | 47.65 | 46.86 | 42.41 |
| PBDTM(%) | 29.72 | 35.30 | 44.19 | 47.65 | 46.86 | 42.41 |
| PATM(%) | -8.21 | 11.46 | 11.07 | 16.54 | 15.43 | 14.51 |